Gliosarcoma: distinct molecular pathways and genomic alterations identified by DNA copy number/SNP microarray analysis

PURPOSE: Gliosarcoma is a histologic variant of glioblastoma (GBM), and like GBM carries a poor prognosis. Median survival is less than one (1) year with less than 5% of patients alive after 5 years. Although there is no cure, standard treatment includes surgery, radiation and chemotherapy. While ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Lowder, Lindsey, Hauenstein, Jennifer, Woods, Ashley, Chen, Hsiao-Rong, Rupji, Manali, Kowalski, Jeanne, Olson, Jeffrey J., Saxe, Debra, Schniederjan, Matthew, Neill, Stewart, Weinberg, Brent, Sengupta, Soma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Laboratory Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591191/
https://www.ncbi.nlm.nih.gov/pubmed/31073965
http://dx.doi.org/10.1007/s11060-019-03184-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591191/
https://www.ncbi.nlm.nih.gov/pubmed/31073965
http://dx.doi.org/10.1007/s11060-019-03184-1

Ejemplares similares